Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Genes · 24.10.2023 · 14 (11) · 1981
DOI: 10.3390/genes14111981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 24.10.2023. Verfasst von Emmanuelle C Genin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research on Cancer and Aging, Nice (IRCAN), Université Côte d'Azur, Inserm U1081, CNRS UMR7284, Centre Hospitalier Universitaire (CHU) …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Mitochondrial dysfunction occurs in numerous neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), where it contributes to motor neuron (MN) death. Of all the factors involved in ALS, mitochondria have been considered as a major player, as secondary mitochondrial dysfunction has been found in various models and patients. Abnormal mitochondrial morphology, defects in mitochondrial dynamics, altered activities of respiratory chain enzymes and increased production of reactive oxygen species have been described. Moreover, the identification of CHCHD10 variants in ALS patients was the first genetic evidence that a mitochondrial defect may be a primary cause of MN damage and directly links mitochondrial dysfunction to the pathogenesis of ALS. In this review, we focus on the role of mitochondria in ALS and highlight the pathogenic variants of ALS genes associated with impaired mitochondrial functions. The multiple pathways demonstrated in ALS pathogenesis suggest that all converge to a common endpoint leading to MN loss. This may explain the disappointing results obtained with treatments targeting a single pathological process. Fighting against mitochondrial dysfunction appears to be a promising avenue for developing combined therapies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Research on Cancer and Aging, Nice (IRCAN), Université Côte d'Azur, Inserm U1081, CNRS UMR7284, Centre Hospitalier Universitaire (CHU) de Nice, 06200 Nice, France.
ORCID-Profile: Emmanuelle C Genin
Förderung
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
Zitieren
APA
Genin, E. C., Abou-Ali, M., & Paquis-Flucklinger, V. (2023). Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis. Genes, 14(11), 1981. https://doi.org/10.3390/genes14111981
Vancouver
Genin EC, Abou-Ali M, Paquis-Flucklinger V. Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis. Genes. 2023;14(11):1981. doi:10.3390/genes14111981
BibTeX
@article{Genin2023,
author = {Genin, Emmanuelle C and Abou-Ali, Mélanie and Paquis-Flucklinger, Véronique},
title = {Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis},
journal = {Genes},
year = {2023},
volume = {14},
number = {11},
pages = {1981},
doi = {10.3390/genes14111981}
}
EUVIMED